CD90 is identified as a marker for cancer stem cells in high-grade gliomas using tissue microarrays

Neurosurgery. 2012 Apr;70(4):N23-4. doi: 10.1227/01.neu.0000413227.80467.92.
No abstract available

Publication types

  • News

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Brain Neoplasms / chemistry
  • Brain Neoplasms / metabolism*
  • Glioma / chemistry
  • Glioma / metabolism*
  • Humans
  • Neoplasm Grading
  • Neoplastic Stem Cells / chemistry
  • Neoplastic Stem Cells / metabolism*
  • Thy-1 Antigens / biosynthesis*
  • Tissue Array Analysis

Substances

  • Biomarkers, Tumor
  • Thy-1 Antigens